Sanitise your face – reduce the risk of infection
JOBURG – Our face is where the infection starts and where we should be fighting the battle against these harmful viruses.
![](https://images.caxton.co.za/wp-content/uploads/sites/6/2021/07/bsafe.jpg)
South Africa battles the third Covid-19 wave, new hope in reducing the risk of infection comes just in time with the launch of an innovative and proven face sanitiser, called Sanitising Facial Mist, produced by proudly South African, Johannesburg-based healthcare technology company, BSafe.
This unique product is set to be a game-changer in the fight against pathogen infection.
It is widely known that Covid-19 and other viruses are airborne and enter our bodies through our face via the mouth, nose and eyes or, by being transferred to our face from our hands. So harmful germs attach, collect, and accumulate on the face causing an increased danger of infection.
Our face is where the infection starts and where we should be fighting the battle against these harmful viruses.
State of the art technology
The new product has been brought to market by BSafe CEO, JJ Viljoen and his team, based on previous technology that the team originally developed for the medical and dentistry industries – industries where a very high and broad degree of top-class, reliable sanitisation is required.
Harnessing the power of previous medical developments
“We harnessed the power of technology to bring a natural, safe and alcohol-free facial sanitiser to the broader public – not as an alternative treatment for Covid-19, but rather as an aid to improving sanitation practices and reducing infection risk,” said Viljoen.
“When we saw this research around just how often we touch our faces and get infected by germs this way, we knew there was an opportunity to do something significant. Our natural facial sanitiser is a vital tool in the armour to fight against contraction of Covid-19 and many other viruses,” explained Viljoen.
SABS and CSIR tested and rated. Up to 99.999%
BSafe production has been successfully tested according to SABS. In Bactericidal and Virucidal tests it was proven to be 99.9999% effective and in Fungicidal and Sporicidal tests over 99.99% effective. It has also been successfully tested against the Coronavirus by the CSIR.
Is this a cure for COVID-19?
“Absolutely not, nor is it an alternative to vaccines, but it’s an important part in the fight against COVID-19, as well as many other infections such as flu’s, measles, colds, pneumonia, TB etc. which are all a massive problem in South Africa,” said Viljoen.
“The new BSafe Sanitising Facial Mist does not replace the need for face masks but rather it is aimed at improving safety. With consistent, everyday application, it will give consumers and medical professionals greater peace of mind that they are better protected against harmful germs and viruses when going about their daily activities,” explained Viljoen.
The new facial sanitiser is not only easily accessible, convenient to use and has SABS and NRCS approval as well as EPA approvals in the USA, but it is also the first in a line of many other innovative products to come all of which are set to have unique indications and benefits to both SA and global consumers alike.